(Q43885601)

English

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914).

scientific article published in December 2001

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

27 November 2017

Cyclosporin A combined with vincristine, doxorubicin and dexamethasone (VAD) compared with VAD alone in patients with advanced refractory multiple myeloma: an EORTC-HOVON randomized phase III study (06914). (English)

1 reference

Europe PubMed Central

27 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Henk M. Lokhorst

7

object named as

H Lokhorst

1 reference

Europe PubMed Central

27 November 2017

author name string

P Sonneveld

1

1 reference

Europe PubMed Central

27 November 2017

S Suciu

2

1 reference

Europe PubMed Central

27 November 2017

P Weijermans

3

1 reference

Europe PubMed Central

27 November 2017

M Beksac

4

1 reference

Europe PubMed Central

27 November 2017

R Neuwirtova

5

1 reference

Europe PubMed Central

27 November 2017

G Solbu

6

1 reference

Europe PubMed Central

27 November 2017

J van der Lelie

8

1 reference

Europe PubMed Central

27 November 2017

H Dohner

9

1 reference

Europe PubMed Central

27 November 2017

H Gerhartz

10

1 reference

Europe PubMed Central

27 November 2017

C M Segeren

11

1 reference

Europe PubMed Central

27 November 2017

R Willemze

12

1 reference

Europe PubMed Central

27 November 2017

B Lowenberg

13

1 reference

Europe PubMed Central

27 November 2017

European Organization for Research and Treatment of Cancer (EORTC)

14

1 reference

Europe PubMed Central

27 November 2017

Leukaemia Cooperative Group (LCG)

15

1 reference

Europe PubMed Central

27 November 2017

Dutch Haemato-Oncology Cooperative Study Group (HOVON)

16

1 reference

Europe PubMed Central

27 November 2017

language of work or name

0 references

publication date

1 December 2001

1 reference

Europe PubMed Central

27 November 2017

British Journal of Haematology

1 reference

Europe PubMed Central

27 November 2017

115

1 reference

Europe PubMed Central

27 November 2017

895-902

1 reference

Europe PubMed Central

27 November 2017

4

1 reference

Europe PubMed Central

27 November 2017

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03171.X

21 January 2018

A phase III randomized study of oral verapamil as a chemosensitizer to reverse drug resistance in patients with refractory myeloma. A Southwest Oncology Group study

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03171.X

21 January 2018

Reversal of drug-resistance in multiple myeloma with verapamil.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03171.X

21 January 2018

Expression of a multidrug-resistance gene in human tumors and tissues

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03171.X

21 January 2018

Verapamil suppresses the emergence of P-glycoprotein-mediated multi-drug resistance

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03171.X

21 January 2018

Combination chemotherapy versus melphalan and prednisolone in the treatment of multiple myeloma: an overview of published trials

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03171.X

21 January 2018

Expression of mdr1 and mdr3 multidrug-resistance genes in human acute and chronic leukemias and association with stimulation of drug accumulation by cyclosporine

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03171.X

21 January 2018

Drug resistance in multiple myeloma: cyclosporin A analogues and their metabolites as potential chemosensitizers.

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03171.X

21 January 2018

Infusion of vincristine and doxorubicin with oral dexamethasone as first-line therapy for multiple myeloma

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03171.X

21 January 2018

Modulation of multidrug-resistant multiple myeloma by cyclosporin. The Leukaemia Group of the EORTC and the HOVON

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2001.03171.X

21 January 2018

Identifiers

10.1046/J.1365-2141.2001.03171.X

1 reference

Europe PubMed Central

27 November 2017

release_47intjoayvf45ixkerqmz4qfia

1 reference

https://api.fatcat.wiki/v0/release/47intjoayvf45ixkerqmz4qfia

24 November 2022

based on heuristic

mapped directly with Wikidata item

1 reference

Europe PubMed Central

27 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43885601&oldid=2104152578"